Cardiovascular disease affects nearly half of the adults in the United States, posing a significant public health challenge.

A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new ...

Background Primary prevention strategies for cardiovascular disease (CVD) conventionally rely on 10-year risk estimates of ...

Biome Analytics has launched the Heart Failure Performance Module, a new addition to its Foundations Reporting platform. This tool is designed to help healthcare professionals improve heart failure ...

RADNOR, Pa. - Mineralys Therapeutics , Inc. (NASDAQ:MLYS), a biopharmaceutical company specializing in the development of treatments for cardiovascular and kidney diseases, has announced the ...

USE ONAPGO is a prescription medicine used to treat motor fluctuations (OFF episodes) in adults with advanced Parkinson’s disease (PD). It is not known if ONAPGO is safe and effective in children.

COVID-19 infection, compared with influenza, is associated with increased myocarditis rates among adults in the United States.

For patients with heart failure, a greater focus on medication management may be needed in order to mitigate exacerbations caused by certain drugs.

Fewer than half of heart patients from 17 countries who could benefit from beneficial drugs are taking them, researchers ...

Statins help people manage high cholesterol levels, but many experts want to know if these drugs can also support brain ...

Epigenetic clocks that quantify rates of aging from DNA methylation patterns across the genome have emerged as a potential biomarker for risk of age-related diseases, like Alzheimer’s disease (AD), ...